Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications
Microorganisms · 06.06.2026 · 14 (6) · 1285
DOI: 10.3390/microorganisms14061285 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 06.06.2026. Verfasst von Christos G Nikolaidis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical School, 'AHEPA' University General Hospital, Aristotle University of Thess…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Type 2 diabetes mellitus is a systemic metabolic disorder with an extensive spectrum of complications, which still persist despite improvements in glycemic control. Emerging evidence suggests that gut dysbiosis may be an underpinning factor in the pathogenesis of both microvascular and macrovascular complications associated with diabetes. This narrative review explores the relationship between gut microbiota and the development of diabetes complications, including nephropathy, retinopathy, neuropathy, cardiovascular, cerebrovascular, peripheral vascular, and reproductive system disorders. First, existing evidence regarding the nature of shared and organ-specific microbial patterns is summarized. Next, key mechanistic pathways of inflammation and metabolism underlying tissue damage induced by dysbiosis are illustrated. Lastly, the role of gut microbiota and inflammaging as modifiers of these processes is described. Emerging clinical and translational implications are finally discussed, underscoring the promises of microbiota-based diagnostics as well as therapeutics that could serve as add-on approaches to the management of diabetic complications, alongside the application of artificial intelligence-based approaches to microbiome data analysis which may enhance biomarker discovery and risk stratification. Overall, although most evidence remains associative, increasing data support that gut microbiota dysbiosis may represent a potential disease modifier in the development of various diabetic complications. Further longitudinal and mechanistic studies are needed to clarify causality and to evaluate the clinical utility of microbiome-targeted interventions, including AI-assisted predictive models, in preventing or mitigating diabetic complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Center, 1st Propaedeutic Department of Internal Medicine, Medical School, 'AHEPA' University General Hospital, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
- 2nd Department of Medicine, Hippokration Hospital, National and Kapodistrian University of Athens, 14564 Athens, Greece.
- Hepatogastroenterology Unit, Academic Department of Internal Medicine, General Oncology Hospital of Kifissia "Agioi Anargyroi", National and Kapodistrian University of Athens, 14564 Athens, Greece.
- Master Program in "Food, Nutrition and Microbiome", Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, University of Lausanne, 1015 Lausanne, Switzerland.
- Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece.
ORCID-Profile: Christos G Nikolaidis, Despoina Gyriki, Elisavet Stavropoulou, Eleni Karlafti, Triantafyllos Didangelos, Christina Tsigalou, Anastasia Thanopoulou
Zitieren
APA
Nikolaidis, C. G., Gyriki, D., Stavropoulou, E., Karlafti, E., Didangelos, T., Tsigalou, C., & Thanopoulou, A. (2026). Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications. Microorganisms, 14(6), 1285. https://doi.org/10.3390/microorganisms14061285
Vancouver
Nikolaidis CG, Gyriki D, Stavropoulou E, Karlafti E, Didangelos T, Tsigalou C, et al. Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications. Microorganisms. 2026;14(6):1285. doi:10.3390/microorganisms14061285
BibTeX
@article{Nikolaidis2026,
author = {Nikolaidis, Christos G and Gyriki, Despoina and Stavropoulou, Elisavet and Karlafti, Eleni and Didangelos, Triantafyllos and Tsigalou, Christina and Thanopoulou, Anastasia},
title = {Gut Microbiota and Diabetic Complications: Potential Mechanisms, Microbial Signatures, and Clinical Implications},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {6},
pages = {1285},
doi = {10.3390/microorganisms14061285}
}
EUVIMED